Prosperitas Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$271K Buy
2,250
+208
+10% +$24K 0.1% 72
2025
Q4
$215K Buy
+2,042
New +$192K 0.08% 74
2025
Q1
Sell
-2,424
Closed -$241K 67
2024
Q4
$241K Buy
+2,424
New +$250K 0.12% 54
2024
Q3
Sell
-2,024
Closed -$251K 71
2024
Q2
$251K Buy
2,024
+2
+0.1% +$258 0.15% 53
2024
Q1
$267K Buy
2,022
+3
+0.1% +$370 0.17% 54
2023
Q4
$220K Sell
2,019
-410
-17% -$42.6K 0.16% 58
2023
Q3
$250K Buy
+2,429
New +$262K 0.19% 60

Other funds holding MRK

Prosperitas Financial's MRK Position: Q1 2026 in Review

Prosperitas Financial increased its Merck (MRK) stake by 10% in Q1 2026, buying an estimated $24K and bringing the position to 2,250 shares worth $271K. The position accounts for 0.1% of the portfolio, ranked #72.

Prosperitas Financial first reported a position in MRK in Q3 2023 and has held it in 7 quarters since. 3,790 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Prosperitas Financial held 2,250 shares of Merck worth $271K as of Q1 2026.
  • Prosperitas Financial bought 208 Merck shares in Q1 2026, an estimated $24K.
  • Merck made up 0.1% of Prosperitas Financial's portfolio in Q1 2026, its #72 holding.
  • Prosperitas Financial first reported a position in Merck in Q3 2023 and has held it in 7 quarters since.
  • 3,790 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Prosperitas Financial's 13F filing for Q1 2026, filed 15 May 2026.